Recipient | Total | Donors |
---|
Profusa is pioneering tissue-integrating biosensors for continuous monitoring of body chemistries. News & Events PROFUSA AND PARTNERS ANNOUNCE INITIATION OF STUDY TO MEASURE EARLY SIGNS OF INFLUENZA THROUGH BIOSENSOR TECHNOLOGY DARPA-Backed Study Leverages Profusa’s Lumee® Oxygen Platform as Part of a Larger Effort to Speed Detection and Predict ... RESEARCH PRESENTED AT LINC SUGGESTS THE PROFUSA LUMEE® OXYGEN PLATFORM MAY IMPROVE CLINICAL MANAGEMENT OF PATIENTS WITH CRITICAL LIMB ISCHEMIA New Insights Come as Profusa Receives CE Mark for Its Latest Generation Device, the Wireless Lumee® Oxygen Platform ... PROFUSA RECEIVES CE MARK APPROVAL TO MARKET THE WIRELESS LUMEE® OXYGEN PLATFORM FOR CONTINUOUS, REAL-TIME MONITORING OF TISSUE OXYGEN Next-Generation Wireless Device May Enable Telehealth And Remote Patient Monitoring in the Future EMERYVILLE, Calif., [January 28, 2020] ... AHA SCIENTIFIC STATEMENT PROFUSA RECOGNIZED BY FROST & SULLIVAN FOR INNOVATION IN THE BIOCHEMICAL SENSORS MARKET Awarded 2018 Entrepreneurial Company of the Year for real-time body chemistry monitoring South San Francisco, Calif. – October ... PROFUSA TO PRESENT AT DARPA D60 SYMPOSIUM Profusa Software and Systems Lead, Kevin Zhao, has been selected to participate in the Defense Advanced Research Projects ... PROFUSA CLOSES $45 MILLION SERIES C FINANCING Leading global investors join this round; financing will accelerate commercialization of Lumee™ Oxygen Platform and pioneering glucose biosensors ... POTENTIAL UTILITY OF TISSUE OXYGEN SENSORS IN PERFUSION MONITORING Novel microsensing technology that reflects microvascular perfusion and oxygen supply in tissue shows promise in patients with chronic limb-threatening ischemia. INJECTABLE BODY SENSORS TAKE PERSONAL CHEMISTRY TO A CELL PHONE CLOSER TO REALITY NEW ORLEANS, March 19, 2018 — Up until now, local inflammation and scar tissue from the so-called “foreign body response” has prevented ... Featured On CESForbes-logoTEDMEDThe Mail On SundayUSA TodayTechTimes Fast CompanyHealthlinelogo DeloitteACS Logo ABOUT US – MANAGEMENT TEAM – PARTNERS & INVESTORS – CAREERS – NEWS & EVENTS OUR VISION LUMEE CONTACT US © 2020 PROFUSA, INC.
Recipient | Total | Donors |
---|